KONDENSIERTE IMIDAZOLDERIVATE ALS MODULATOREN VIELFACHER MEDIKAMENTENRESISTENZ

This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydrogen; halo; formyl; C1-4alkyl optionally substituted with hydroxy, C1...

Full description

Saved in:
Bibliographic Details
Main Authors SURLERAUX, LOUIS, SOMMEN, MARIA, LEENAERTS, ELISABETH, JANSSENS, EDUARD
Format Patent
LanguageGerman
Published 24.09.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydrogen; halo; formyl; C1-4alkyl optionally substituted with hydroxy, C1-4alkyloxy, C1-4alkylcarbonyloxy, imidazolyl, thiazolyl or oxazolyl; or a radical of formula -X-COOR5, -X-CONR6R7 or -X-COR10 wherein -X- is a direct bond, C1-4alkanediyl or C2-6alkenediyl; R5 is hydrogen, C1-12alkyl, Ar, Het, C1-6alkyl substituted with C1-4alkyloxy, aryl or heteroaryl; R6 and R7 each independently are hydrogen or C1-4alkyl; R2 is hydrogen, halo, C1-4alkyl, hydroxyC1-4alkyl, C1-4alkyloxycarbonyl, carboxyl, formyl or phenyl; R3 is hydrogen, C1-4alkyl or C1-4alkyloxy; R4 is hydrogen, halo, C1-4alkyl, C1-4alkyloxy or haloC1-4alkyl; Z is -CH2-, -CH2-CH2-, -CH=CH-, -CHOH-CH2-, -O-CH2-, -C(=O)-CH2- or -C(=NOH)-CH2-; -A-B- is a bivalent radical; A1 is a direct bond, optionally substituted C1-6alkanediyl, C1-6alkanediyl-oxy-C1-6alkanediyl, carbonyl, C1-6alkanediylcarbonyl, optionally substituted C1-6alkanediyloxy; A2 is a direct bond or C1-6alkanediyl; and Q is aryl. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for inhibiting or reversing the effects of multidrug resistance.
AbstractList This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydrogen; halo; formyl; C1-4alkyl optionally substituted with hydroxy, C1-4alkyloxy, C1-4alkylcarbonyloxy, imidazolyl, thiazolyl or oxazolyl; or a radical of formula -X-COOR5, -X-CONR6R7 or -X-COR10 wherein -X- is a direct bond, C1-4alkanediyl or C2-6alkenediyl; R5 is hydrogen, C1-12alkyl, Ar, Het, C1-6alkyl substituted with C1-4alkyloxy, aryl or heteroaryl; R6 and R7 each independently are hydrogen or C1-4alkyl; R2 is hydrogen, halo, C1-4alkyl, hydroxyC1-4alkyl, C1-4alkyloxycarbonyl, carboxyl, formyl or phenyl; R3 is hydrogen, C1-4alkyl or C1-4alkyloxy; R4 is hydrogen, halo, C1-4alkyl, C1-4alkyloxy or haloC1-4alkyl; Z is -CH2-, -CH2-CH2-, -CH=CH-, -CHOH-CH2-, -O-CH2-, -C(=O)-CH2- or -C(=NOH)-CH2-; -A-B- is a bivalent radical; A1 is a direct bond, optionally substituted C1-6alkanediyl, C1-6alkanediyl-oxy-C1-6alkanediyl, carbonyl, C1-6alkanediylcarbonyl, optionally substituted C1-6alkanediyloxy; A2 is a direct bond or C1-6alkanediyl; and Q is aryl. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for inhibiting or reversing the effects of multidrug resistance.
Author SURLERAUX, LOUIS
LEENAERTS, ELISABETH
SOMMEN, MARIA
JANSSENS, EDUARD
Author_xml – fullname: SURLERAUX, LOUIS
– fullname: SOMMEN, MARIA
– fullname: LEENAERTS, ELISABETH
– fullname: JANSSENS, EDUARD
BookMark eNqNyrsKwjAYhuEMOni6h-DukoLaMTRf6U9zgCR26FKKxEnSQr1_7OAFOD3w8u7ZJk857ZhtnVWwgeAjOBlSsndawVMn1yB14Maph5bReVjeEXQtqwaeGyhqpYGNsB6Bwmp_ZNvX-F7S6eeBnWvEqrmkeRrSMo_PlNNnULiWNyGKexmjKP6avgzLMec
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DE69722389TT2
GroupedDBID EVB
ID FETCH-epo_espacenet_DE69722389TT23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:11:24 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DE69722389TT23
Notes Application Number: DE19976022389T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090924&DB=EPODOC&CC=DE&NR=69722389T2
ParticipantIDs epo_espacenet_DE69722389TT2
PublicationCentury 2000
PublicationDate 20090924
PublicationDateYYYYMMDD 2009-09-24
PublicationDate_xml – month: 09
  year: 2009
  text: 20090924
  day: 24
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies JANSSEN PHARMACEUTICA N.V
RelatedCompanies_xml – name: JANSSEN PHARMACEUTICA N.V
Score 2.7387218
Snippet This invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title KONDENSIERTE IMIDAZOLDERIVATE ALS MODULATOREN VIELFACHER MEDIKAMENTENRESISTENZ
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090924&DB=EPODOC&locale=&CC=DE&NR=69722389T2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haNSbokZFzWLMbosIG2OHxYy1yyajIzAI4ULoWhI9AJEZ_31fx4eeOLVpk5f2Je_j19f-CvDctBE0SCEN0TIRoPDXhsFFXRq1Frcyx8pEtrltwZrh0HwfW-MSfO7ewhQ8oT8FOSJaVIb2nhf-evV3iEWKu5XrF_6BQ8u3IHWJvkPHTg3xhE7aLu0lJPF133cJ1VnfbTo2BsKWk6K7PlJptOLZp6O2epWy-h9SgnM47qG0RX4BJSErcOrvfl6rwEl3W_DG7tb21pfAOgkjlA0iiimohj6HeJMkJgjERh4OePFA6yZkGHtp0qdMG0U0Djw_pH1NUTh2PMXaTxkqPBpgO7mCp4CmfmjgwqZ7LUwJ3e8hrTeuobxYLuQNaGJmW8LiPJuZAvXOHW4qTFh3zLkt57x2C9UDgu4OzlbhbFM9UVWYeyjnX9_yAYNwzh8L7f0CwbSF_A
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokbFj8WY3RYRNsYOixlrl01GR2AshAuh60j0AERm_Pd9HR964tSmTV7al7yPX1_7K8Bzy0TQkIlME20dAQp_bWpcNDKt3uZGahmpSDe3LVjLH-nvY2Ncgs_dW5iCJ_SnIEdEi0rR3vPCX6_-DrFIcbdy_cI_cGj55sU2UXfo2KojnlBJx6b9iESu6ro2oSob2C3LxEDYtmJ010emZOeVqVPSka9SVv9DincGx32UtsjPoSSyKlTc3c9rVTjpbQve2N3a3voCWDdihLJhQDEFVdDnEGcShQSBWOLggBMOlV5ERqETRwPKlCSgoee4Ph0oksKx60jWfspQ4cEQ28klPHk0dn0NFzbda2FK6H4PcaN5BeXFcpFdgyJmpiEMztOZLlDv3OK6xIQNS5-b2ZzXb6B2QNDtwdlHqPhxL5yGAevW4HRTSZEVmTso51_f2T0G5Jw_FJr8BS5EiOk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=KONDENSIERTE+IMIDAZOLDERIVATE+ALS+MODULATOREN+VIELFACHER+MEDIKAMENTENRESISTENZ&rft.inventor=SURLERAUX%2C+LOUIS&rft.inventor=SOMMEN%2C+MARIA&rft.inventor=LEENAERTS%2C+ELISABETH&rft.inventor=JANSSENS%2C+EDUARD&rft.date=2009-09-24&rft.externalDBID=T2&rft.externalDocID=DE69722389TT2